Ischemia, immunosuppression and infection-tackling the predicaments of post-stroke complications

International Journal of Molecular Sciences

Volumn 17, Issue 1, 2016, Pages 1-18

  Shim, Raymond ^a   Wong, Connie H Y ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antibiotics; Clinical outcome; Immunosuppression; Infection; Stroke

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MOXIFLOXACIN; PENICILLIN DERIVATIVE; SUBSTANCE P; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; IMMUNOLOGIC FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASPIRATION; BACTERIAL LOAD; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DYSPHAGIA; ESCHERICHIA COLI; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; ISCHEMIA; LYMPHOCYTOPENIA; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGICAL COMPLICATION; NONHUMAN; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY BURST; REVIEW; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; ANIMAL; BRAIN; BRAIN ISCHEMIA; COMPLICATION; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN; BRAIN ISCHEMIA; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; INFECTION; STROKE;

EID: 84954446735     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17010064     Document Type: Review

References (128)

1. Feigin, V.L.; Forouzanfar, M.H.; Krishnamurthi, R.; Mensah, G.A.; Connor, M.; Bennett, D.A.; Moran, A.E.; Sacco, R.L.; Anderson, L.; Truelsen, T. et al. Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease study 2010. Lancet 2014, 383, 245-255.
2. Mackay, J.; Mensah, G.A. The atlas of heart disease and stroke. In The Atlas of Heart Disease and Stroke; Ann, H., Ed.; World Heath Organisation: Geneva, Switzerland, 2004; Chapter 16; pp. 52-53.
3. Strong, K.; Mathers, C.; Bonita, R. Preventing stroke: Saving lives around the world. Lancet Neurol. 2007, 6, 182-187.
4. Cadilhac, D.A.; Carter, R.; Thrift, A.G.; Dewey, H.M. Estimating the long-term costs of ischemic and hemorrhagic stroke for australia: New evidence derived from the north east melbourne stroke incidence study (NEMESIS). Stroke 2009, 40, 915-921.
5. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; de Ferranti, S.; Despres, J.P.; Fullerton, H.J.; Howard, V.J. et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015,131, e29-e322.
6. Lai, T.W.; Zhang, S.; Wang, Y.T. Excitotoxicity and stroke: Identifying novel targets for neuroprotection. Prog. Neurobiol. 2014,115,157-188.
7. Chu, K.; Lee, S.T.; Sinn, D.I.; Ko, S.Y.; Kim, E.H.; Kim, J.M.; Kim, S.J.; Park, D.K.; Jung, K.H.; Song, E.C. et al. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 2007, 38, 177-182.
8. Sims, N.R.; Muyderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta BBA Mol. Basis Dis. 2010,1802, 80-91.
9. Bohacek, I.; Cordeau, P.; Lalancette-Hebert, M.; Gorup, D.; Weng, Y.-C.; Gajovic, S.; Kriz, J. Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J. Neuroinflamm. 2012, 9, 2094-2099.
10. Liesz, A.; Dalpke, A.; Mracsko, E.; Antoine, D.J.; Roth, S.; Zhou, W.; Yang, H.; Na, S.Y.; Akhisaroglu, M.; Fleming, T. et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J. Neurosci. 2015, 35, 583-598.
11. Sansing, L.H.; Harris, T.H.; Welsh, F.A.; Kasner, S.E.; Hunter, C.A.; Kariko, K. Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann. Neurol. 2011, 70, 646-656.
12. Yilmaz, G.; Granger, D.N. Leukocyte recruitment and ischemic brain injury. Neuromol. Med. 2010,12,193-204.
13. Gertz, K.; Kronenberg, G.; Kälin, R.E.; Baldinger, T.; Werner, C.; Balkaya, M.; Eom, G.D.; Hellmann-Regen, J.; Krober, J.; Miller, K.R. et al. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 2012, 135, 1964-1980.
14. Pradillo, J.M.; Denes, A.; Greenhalgh, A.D.; Boutin, H.; Drake, C.; McColl, B.W.; Barton, E.; Proctor, S.D.; Russell, J.C.; Rothwell, N.J. et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab. 2012, 32,1810-1819.
15. Savage, C.D.; Lopez-Castejon, G.; Denes, A.; Brough, D. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front. Immunol. 2012, 3, 288.
16. Lenglet, S.; Montecucco, F.; Denes, A.; Coutts, G.; Pinteaux, E.; Mach, F.; Schaller, K.; Gasche, Y.; Copin, J.C. Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice. J. Cereb. Blood Flow Metab. 2014, 34,802-812.
17. Ruscher, K.; Kuric, E.; Liu, Y.; Walter, H.L.; Issazadeh-Navikas, S.; Englund, E.; Wieloch, T. Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J. Cereb. Blood Flow Metab. 2013, 33,1225-1234.
18. Liesz, A.; Zhou, W.; Mracskó, É.; Karcher, S.; Bauer, H.; Schwarting, S.; Sun, L.; Bruder, D.; Stegemann, S.; Cerwenka, A. et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 2011,134, 704-720.
19. Abramov, A.Y.; Scorziello, A.; Duchen, M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 2007, 27, 1129-1138.
20. Heuschmann, P.U.; Kolominsky-Rabas, P.L.; Misselwitz, B.; Hermanek, P.; Leffmann, C.; Janzen, R.; Rother, J.; Buecker-Nott, H.-J.; Berger, K. et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German Stroke Registers Study Group. Arch. Intern. Med. 2004,164,1761-1768.
21. Vahedi, K.; Hofmeijer, J.; Juettler, E.; Vicaut, E.; George, B.; Algra, A.; Amelink, G.J.; Schmiedeck, P.; Schwab, S.; Rothwell, P.M. et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol. 2007, 6, 215-222.
22. Gelderblom, M.; Leypoldt, F.; Steinbach, K.; Behrens, D.; Choe, C.U.; Siler, D.A.; Arumugam, T.V.; Orthey, E.; Gerloff, C.; Tolosa, E. et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40,1849-1857.
23. Gliem, M.; Mausberg, A.K.; Lee, J.I.; Simiantonakis, I.; van Rooijen, N.; Hartung, H.P.; Jander, S. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann. Neurol. 2012, 71, 743-752.
24. Kleinschnitz, C.; Bendszus, M.; Frank, M.; Solymosi, L.; Toyka, K.V.; Stoll, G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2003,23,1356-1361.
25. Clausen, B.H.; Lambertsen, K.L.; Babcock, A.A.; Holm, T.H.; Dagnaes-Hansen, F.; Finsen, B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflamm. 2008, 5, 46.
26. Gregersen, R.; Lambertsen, K.; Finsen, B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 2000, 20, 53-65.
27. Hu, X.; Li, P.; Guo, Y.; Wang, H.; Leak, R.K.; Chen, S.; Gao, Y.; Chen, J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012, 43, 3063-3070.
28. Buck, B.H.; Liebeskind, D.S.; Saver, J.L.; Bang, O.Y.; Yun, S.W.; Starkman, S.; Ali, L.K.; Kim, D.; Villablanca, J.P.; Salamon, N. et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 2008, 39, 355-360.
29. Li, M.; Qu, Y.Z.; Zhao, Z.W.; Wu, S.X.; Liu, Y.Y.; Wei, X.Y.; Gao, L.; Gao, G.D. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem. Int. 2012, 60, 458-465.
30. Morrison, H.; McKee, D.; Ritter, L. Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion. Biol. Res. Nurs. 2011,13,154-163.
31. Price, C.; Menon, D.; Peters, A.; Ballinger, J.; Barber, R.; Balan, K.; Lynch, A.; Xuereb, J.; Fryer, T.; Guadagno, J. et al. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: An imaging-based study. Stroke 2004, 35,1659-1664.
32. Harris, A.K.; Ergul, A.; Kozak, A.; Machado, L.S.; Johnson, M.H.; Fagan, S.C. Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci. 2005, 6, 49.
33. Cuartero, M.I.; Ballesteros, I.; Moraga, A.; Nombela, F.; Vivancos, J.; Hamilton, J.A.; Corbi, A.L.; Lizasoain, I.; Moro, M.A. N2 neutrophils, novel players in brain inflammation after stroke modulation by the PPARy agonist rosiglitazone. Stroke 2013, 44, 3498-3508.
34. Hurn, P.D.; Subramanian, S.; Parker, S.M.; Afentoulis, M.E.; Kaler, L.J.; Vandenbark, A.A.; Offner, H. T-and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 2007, 27,1798-1805.
35. Kleinschnitz, C.; Schwab, N.; Kraft, P.; Hagedorn, I.; Dreykluft, A.; Schwarz, T.; Austinat, M.; Nieswandt, B.; Wiendl, H.; Stoll, G. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010,115, 3835-3842.
36. Yilmaz, G.; Arumugam, T.V.; Stokes, K.Y.; Granger, D.N. Role of T lymphocytes and interferon-y in ischemic stroke. Circulation 2006,113,2105-2112.
37. Offner, H.; Hurn, P.D. A novel hypothesis: Regulatory B lymphocytes shape outcome from experimental stroke. Transl. Stroke Res. 2012, 3, 324-330.
38. Ren, X.; Akiyoshi, K.; Dziennis, S.; Vandenbark, A.A.; Herson, P.S.; Hurn, P.D.; Offner, H. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 2011, 31, 8556-8563.
39. Jin, R.; Yang, G.; Li, G. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc. Biol. 2010, 87, 779-789.
40. Liesz, A.; Suri-Payer, E.; Veltkamp, C.; Doerr, H.; Sommer, C.; Rivest, S.; Giese, T.; Veltkamp, R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 2009,15,192-199.
41. Kleinschnitz, C.; Kraft, P.; Dreykluft, A.; Hagedorn, I.; Gobel, K.; Schuhmann, M.K.; Langhauser, F.; Helluy, X.; Schwarz, T.; Bittner, S. et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013,121, 679-691.
42. Lo, E.H. A new penumbra: Transitioning from injury into repair after stroke. Nat. Med. 2008,14, 497-500.
43. Fu, Y.; Liu, Q.; Anrather, J.; Shi, F.D. Immune interventions in stroke. Nat. Rev. Neurol. 2015,11, 524-535.
44. Langhauser, F.; Kraft, P.; Göb, E.; Leinweber, J.; Schuhmann, M.K.; Lorenz, K.; Gelderblom, M.; Bittner, S.; Meuth, S.G.; Wiendl, H. et al. Blocking of a4 integrin does not protect from acute ischemic stroke in mice.Stroke 2014, 45,1799-1806.
45. Schäbitz, W.R.; Dirnagl, U. Are we ready to translate T-cell transmigration in stroke? Stroke 2014, 45, 1610-1611.
46. Schwab, S.R.; Pereira, J.P.; Matloubian, M.; Xu, Y.; Huang, Y.; Cyster, J.G. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005, 309,1735-1739.
47. Wei, Y.; Yemisci, M.; Kim, H.H.; Yung, L.M.; Shin, H.K.; Hwang, S.K.; Guo, S.; Qin, T.; Alsharif, N.; Brinkmann, V. et al. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 2011, 69,119-129.
48. Campos, F.; Qin, T.; Castillo, J.; Seo, J.H.; Arai, K.; Lo, E.H.; Waeber, C. Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke 2013, 44, 505-511.
49. Fu, Y.; Zhang, N.; Ren, L.; Yan, Y.; Sun, N.; Li, Y.J.; Han, W.; Xue, R.; Liu, Q.; Hao, J. et al. Impact of an immune modulator fingolimod on acute ischemic stroke. Proc. Natl. Acad. Sci. USA 2014,111,18315-18320.
50. Khatri, R.; McKinney, A.M.; Swenson, B.; Janardhan, V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 2012, 79, S52-S57.
51. Liu, J.; Jin, X.; Liu, K.J.; Liu, W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci. 2012, 32, 3044-3057.
52. Renú, A.; Amaro, S.; Laredo, C.; San Román, L.; Llull, L.; Lopez, A.; Urra, X.; Blasco, J.; Oleaga, L.; Chamorro, Á. Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke dual-energy computed tomographic study. Stroke 2015, 46, 673-679.
53. Becker, K.J.; Kalil, A.J.; Tanzi, P.; Zierath, D.K.; Savos, A.V.; Gee, J.M.; Hadwin, J.; Carter, K.T.; Shibata, D.; Cain, K.C. Autoimmune responses to the brain after stroke are associated with worse outcome. Stroke 2011, 42, 2763-2769.
54. Gan, Y.; Liu, Q.; Wu, W.; Yin, J.X.; Bai, X.F.; Shen, R.; Wang, Y.; Chen, J.; La Cava, A.; Poursine-Laurent, J. et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc. Natl. Acad. Sci. USA 2014, 111,2704-2709.
55. Planas, A.M.; Gomez-Choco, M.; Urra, X.; Gorina, R.; Caballero, M.; Chamorro, Á. Brain-derived antigens in lymphoid tissue of patients with acute stroke. J. Immunol. 2012,188, 2156-2163.
56. Langhorne, P.; Stott, D.; Robertson, L.; MacDonald, J.; Jones, L.; McAlpine, C.; Dick, F.; Taylor, G.; Murray, G. Medical complications after stroke a multicenter study. Stroke 2000, 31,1223-1229.
57. Vernino, S.; Brown, R.D.; Sejvar, J.J.; Sicks, J.D.; Petty, G.W.; O’Fallon, W.M. Cause-specific mortality after first cerebral infarction a population-based study. Stroke 2003, 34,1828-1832.
58. Corrado, E.; Rizzo, M.; Tantillo, R.; Muratori, I.; Bonura, F.; Vitale, G.; Novo, S. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: A 5-year follow-up study. Stroke 2006, 37, 482-486.
59. Kimura, K.; Minematsu, K.; Kazui, S.; Yamaguchi, T. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc. Dis. 2005,19,171-178.
60. Ulm, L.; Harms, H.; Ohlraun, S.; Reimnitz, P.; Meisel, A. Impact of infections on long-term outcome after severe middle cerebral artery infarction. J. Neurol. Sci. 2012, 319,15-17.
61. Wilson, R.D. Mortality and cost of pneumonia after stroke for different risk groups. J. Stroke Cerebrovasc. Dis.2012, 21, 61-67.
62. Smith, C.J.; Emsley, H.C.; Gavin, C.M.; Georgiou, R.F.; Vail, A.; Barberan, E.M.; del Zoppo, G.J.; Hallenbeck, J.M.; Rothwell, N.J.; Hopkins, S.J. et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4, 2.
63. Whiteley, W.; Jackson, C.; Lewis, S.; Lowe, G.; Rumley, A.; Sandercock, P.; Wardlaw, J.; Dennis, M.; Sudlow, C. Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009, 8, e1000145.
64. Wong, A.A.; Davis, J.P.; Schluter, P.J.; Henderson, R.D.; O’Sullivan, J.D.; Read, S.J. The time course and determinants of temperature within the first 48 h after ischaemic stroke. Cerebrovasc. Dis. 2007, 24,104-110.
65. Patel, M.; Kulendran, A. Infections after stroke. In Management of Post-Stroke Complications; Springer: Cham, Switzerland, 2015; pp. 51-62.
66. Esayag, Y.; Nikitin, I.; Bar-Ziv, J.; Cytter, R.; Hadas-Halpern, I.; Zalut, T.; Yinnon, A.M. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am. J. Med. 2010,123, 88. e1-88. e5.
67. Hetze, S.; Engel, O.; Römer, C.; Mueller, S.; Dirnagl, U.; Meisel, C.; Meisel, A. Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: A bed to bench approach. J. Cereb. Blood Flow Metab. 2013, 33, 846-854.
68. Walter, U.; Knoblich, R.; Steinhagen, V.; Donat, M.; Benecke, R.; Kloth, A. Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J. Neurol. 2007, 254,1323-1329.
69. Harms, H.; Grittner, U.; Dröge, H.; Meisel, A. Predicting post-stroke pneumonia: The pantheris score. Acta Neurol. Scand. 2013,128,178-184.
70. Haeusler, K.G.; Schmidt, W.U.; Fohring, F.; Meisel, C.; Helms, T.; Jungehulsing, G.J.; Nolte, C.H.; Schmolke, K.; Wegner, B.; Meisel, A. et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 2008, 25, 50-58.
71. Meisel, A.; Meisel, C.; Harms, H.; Hartmann, O.; Ulm, L. Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc. Dis. 2012, 33, 580-588.
72. Vogelgesang, A.; Grunwald, U.; Langner, S.; Jack, R.; Broker, B.M.; Kessler, C.; Dressel, A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008, 39, 237-241.
73. Chapman, K.Z.; Dale, V.Q.; Dénes, Á.; Bennett, G.; Rothwell, N.J.; Allan, S.M.; McColl, B.W. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J. Cereb. Blood Flow Metab. 2009,29,1764-1768.
74. Romer, C.; Engel, O.; Winek, K.; Hochmeister, S.; Zhang, T.; Royl, G.; Klehmet, J.; Dirnagl, U.; Meisel, C.; Meisel, A. Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke. J. Neurosci. 2015, 35, 7777-7794.
75. Mantovani, A.; Cassatella, M.A.; Costantini, C.; Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011,11, 519-531.
76. Seki, Y.; Sahara, Y.; Itoh, E.; Kawamura, T. Suppressed neutrophil respiratory burst in patients with haemorrhagic stroke. J. Clin. Neurosci. 2010,17,187-190.
77. Ruhnau, J.; Schulze, K.; Gaida, B.; Langner, S.; Kessler, C.; Bröker, B.; Dressel, A.; Vogelgesang, A. Stroke alters respiratory burst in neutrophils and monocytes. Stroke 2014, 45, 794-800.
78. Sica, A.; Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Investig. 2012,122, 787-795.
79. Offner, H.; Subramanian, S.; Parker, S.M.; Afentoulis, M.E.; Vandenbark, A.A.; Hurn, P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006, 26, 654-665.
80. Iwasaki, A.; Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, 16, 343-353.
81. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449, 819-826.
82. Vogelgesang, A.; Becker, K.; Dressel, A. Immunological consequences of ischemic stroke. Acta Neurol. Scand.2014, 129,1-12.
83. Haeusler, K.G.; Schmidt, W.U.; Foehring, F.; Meisel, C.; Guenther, C.; Brunecker, P.; Kunze, C.; Helms, T.; Dirnagl, U.; Volk, H.D. et al. Immune responses after acute ischemic stroke or myocardial infarction. Int. J. Cardiol. 2012,155, 372-377.
84. Hug, A.; Liesz, A.; Muerle, B.; Zhou, W.; Ehrenheim, J.; Lorenz, A.; Dalpke, A.; Veltkamp, R. Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 2011, 42, 3580-3586.
85. Prass, K.; Meisel, C.; Höflich, C.; Braun, J.; Halle, E.; Wolf, T.; Ruscher, K.; Victorov, I.V.; Priller, J.; Dirnagl, U. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003,198, 725-736.
86. Offner, H.; Subramanian, S.; Parker, S.M.; Wang, C.; Afentoulis, M.E.; Lewis, A.; Vandenbark, A.A.; Hurn, P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 2006,176, 6523-6531.
87. + T cells in patients at the post-acute phase of stroke. Clin. Exp. Immunol. 2008,152, 456-463.
88. Chamorro, A.; Horcajada, J.; Obach, V.; Vargas, M.; Revilla, M.; Torres, F.; Cervera, A.; Planas, A.; Mensa, J. The early systemic prophylaxis of infection after stroke study a randomized clinical trial. Stroke 2005, 36, 1495-1500.
89. Engelbertsen, D.; Andersson, L.; Ljungcrantz, I.; Wigren, M.; Hedblad, B.; Nilsson, J.; Bjorkbacka, H. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler. Thromb. Vasc. Biol.2013, 33, 637-644.
90. Klehmet, J.; Harms, H.; Richter, M.; Prass, K.; Volk, H.; Dirnagl, U.; Meisel, A.; Meisel, C. Stroke-induced immunodepression and post-stroke infections: Lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009,158,1184-1193.
91. Chamorro, A.; Amaro, S.; Vargas, M.; Obach, V.; Cervera, Á.; Torres, F.; Planas, A.M. Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2006, 77, 1279-1281.
92. Emsley, H.C.A.; Smith, C.J.; Gavin, C.M.; Georgiou, R.F.; Vail, A.; Barberan, E.M.; Hallenbeck, J.M.; del Zoppo, G.J.; Rothwell, N.J.; Tyrrell, P.J. et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: Relationships with infection and atherosclerosis. J. Neuroimmunol. 2003,139, 93-101.
93. Haddad, J.J.; Saade, N.E.; Safieh-Garabedian, B. Cytokines and neuro-immune-endocrine interactions: A role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 2002,133,1-19.
94. Anne, M.; Juha, K.; Makikallio, T.; Mikko, T.; Olli, V.; Kyosti, S.; Heikki, H.; Vilho, M. Neurohormonal activation in ischemic stroke: Effects of acute phase disturbances on long-term mortality. Curr. Neurovasc. Res. 2007, 4,170-175.
95. Brambilla, R.; Couch, Y.; Lambertsen, K.L. The effect of stroke on immune function. Mol. Cell. Neurosci. 2013, 26-33.
96. Vogelgesang, A.; May, V.E.; Grunwald, U.; Bakkeboe, M.; Langner, S.; Wallaschofski, H.; Kessler, C.; Broker, B.M.; Dressel, A. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS ONE 2010, 5, e8718.
97. Wong, C.H.; Jenne, C.N.; Lee, W.Y.; Léger, C.; Kubes, P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334,101-105.
98. Mracsko, E.; Liesz, A.; Karcher, S.; Zorn, M.; Bari, F.; Veltkamp, R. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain, Behav. Immun. 2014, 41, 200-209.
99. Yeh, S.J.; Huang, K.Y.; Wang, T.G.; Chen, Y.C.; Chen, C.H.; Tang, S.C.; Tsai, L.K.; Yip, P.K.; Jeng, J.S. Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit. J. Neurol. Sci. 2011, 306, 38-41.
100. Ersoz, M.; Ulusoy, H.; Oktar, M.A.; Akyuz, M. Urinary tract infection and bacteriurua in stroke patients: Frequencies, pathogen microorganisms, and risk factors. Am. J.Phys. Med. Rehabil. 2007, 86,734-741.
101. Teramoto, S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev. Neurother.2009, 9,1187-1200.
102. Arai, T.; Yoshimi, N.; Fujiwara, H.; Sekizawa, K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology 2003, 61,1625-1626.
103. Smithard, D.; O’neill, P.; Park, C.; Morris, J.; Wyatt, R.; England, R.; Martin, D.F. Complications and outcome after acute stroke does dysphagia matter? Stroke 1996,27,1200-1204.
104. Kumar, S.; Selim, M.H.; Caplan, L.R. Medical complications after stroke. Lancet Neurol. 2010, 9,105-118.
105. Prass, K.; Braun, J.S.; Dirnagl, U.; Meisel, C.; Meisel, A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006, 37, 2607-2612.
106. Dziewas, R.; Ritter, M.; Schilling, M.; Konrad, C.; Oelenberg, S.; Nabavi, D.; Stögbauer, F.; Ringelstein, E.; Ludemann, P. Pneumonia in acute stroke patients fed by nasogastric tube. J. Neurol. Neurosurg. Psychiatry 2004, 75, 852-856.
107. Vargas, M.; Horcajada, J.P.; Obach, V.; Revilla, M.; Cervera, Á.; Torres, F.; Planas, A.M.; Mensa, J.; Chamorro, Á. Clinical consequences of infection in patients with acute stroke is it prime time for further antibiotic trials? Stroke 2006, 37, 461-465.
108. Harms, H.; Prass, K.; Meisel, C.; Klehmet, J.; Rogge, W.; Drenckhahn, C.; Göhler, J.; Bereswill, S.; Göbel, U.; Wernecke, K.D. et al. Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial. PLoS ONE 2008, 3, e2158.
109. Yan, L.; Qing, Y.; Xingyi, J.; Hongbo, Q. Etiologic diagnosis and clinical treatment of multiple drug-resistant bacteria infection in elderly patients with stroke-associated pneumonia after neurosurgery. Cell Biochem. Biophys. 2015, 71, 731-734.
110. Jones, R.N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 2010, 51 (Suppl. 1), S81-S87.
111. Laban, K.G.; Rinkel, G.J.; Vergouwen, M.D.I. Nosocomial infections after aneurysmal subarachnoid hemorrhage: Time course and causative pathogens. Int. J. Stroke 2015,10, 763-766.
112. Westendorp, W.F.; Nederkoorn, P.J.; Vermeij, J.D.; Dijkgraaf, M.G.; van de Beek, D. Post-stroke infection: A systematic review and meta-analysis. BMC Neurol. 2011,11,110.
113. Urra, X.; Miró, F.; Chamorro, A.; Planas, A.M. Antigen-specific immune reactions to ischemic stroke. Front. Cell. Neurosci. 2014, 8, 278.
114. Becker, K. Autoimmune responses to brain following stroke. Transl.Stroke Res. 2012, 3, 310-317.
115. Becker, K.J.; Kindrick, D.L.; Lester, M.P.; Shea, C.; Ye, Z.C. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J. Cereb. Blood Flow Metab. 2005, 25,1634-1644.
116. Dénes, Á.; Ferenczi, S.; Kovács, K.J. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflamm. 2011, 8, 164.
117. Aslanyan, S.; Weir, C.; Diener, H.C.; Kaste, M.; Lees, K.R. Pneumonia and urinary tract infection after acute ischaemic stroke: A tertiary analysis of the GAIN international trial. Eur. J. Neurol. 2004, 11, 49-53.
118. Meisel, C.; Prass, K.; Braun, J.; Victorov, I.; Wolf, T.; Megow, D.; Halle, E.; Volk, H.D.; Dirnagl, U.; Meisel, A. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 2004, 35, 2-6.
119. Amiri-Nikpour, M.R.; Nazarbaghi, S.; Hamdi-Holasou, M.; Rezaei, Y. An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: Gender-dependent effect. Acta Neurol. Scand.2015,131,45-50.
120. Schwarz, S.; Al-Shajlawi, F.; Sick, C.; Meairs, S.; Hennerici, M.G. Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: The Mannheim infection in stroke study (MISS). Stroke 2008, 39,1220-1227.
121. Westendorp, W.F.; Vermeij, J. D.; Zock, E.; Hooijenga, I.J.; Kruyt, N.D.; Bosboom, H.J.; Kwa, V.I.; Weisfelt, M.; Remmers, M.J.; ten Houten, R. et al. The preventive antibiotics in stroke study (PASS): A pragmatic randomised open-label masked endpoint clinical trial. Lancet 2015, 385,1519-1526.
122. Rothstein, J.D.; Patel, S.; Regan, M.R.; Haenggeli, C.; Huang, Y.H.; Bergles, D.E.; Jin, L.; Hoberg, M.D.; Vidensky, S.; Chung, D.S. et al. |β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433, 73-77.
123. Zhang, S.; He, W.-B.; Chen, N.H. Causes of death among persons who survive an acute ischemic stroke. Curr. Neurol. Neurosci. Rep. 2014,14,1-11.
124. Van de Beek, D.; Wijdicks, E.F.; Vermeij, F.H.; de Haan, R.J.; Prins, J.M.; Spanjaard, L.; Dippel, D.W.; Nederkoorn, P.J. Preventive antibiotics for infections in acute stroke: A systematic review and meta-analysis. Arch. Neurol. 2009, 66,1076-1081.
125. Kalra, L.; Irshad, S.; Hodsoll, J.; Simpson, M.; Gulliford, M.; Smithard, D.; Patel, A.; Rebollo-Mesa, I.; Investigators, S.-I. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): A prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015, 386,1835-1844.
126. Dziedzic, T.; Slowik, A.; Pera, J.; Szczudlik, A. Beta-blockers reduce the risk of early death in ischemic stroke. J. Neurol. Sci. 2007,252, 53-56.
127. Sykora, M.; Siarnik, P.; Diedler, J.; Lees, K.; Alexandrov, A.; Bath, P.; Bluhmki, E.; Bornstein, N.; Claesson, L.; Davis, S. et al. |3-blockers, pneumonia, and outcome after ischemic stroke evidence from virtual international stroke trials archive. Stroke 2015, 46,1269-1274.
128. Maier, I.L.; Karch, A.; Mikolajczyk, R.; Bähr, M.; Liman, J. Effect of Beta-blocker therapy on the risk of infections and death after acute stroke-a historical cohort study. PLoS ONE 2015, 10, e0116836.